Genocea Biosciences is a biopharmaceutical company specializing in the development of vaccines and immunotherapies to treat infectious diseases. The company employs its proprietary discovery platform, AnTigen Lead Acquisition System, to design innovative vaccines and immunotherapies that act through T cell immune responses.